本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Catalyst Pharmaceutical Partners

21.89
+0.35001.62%
盤後21.84-0.0500-0.23%16:59 EDT
成交量:101.67萬
成交額:2,217.40萬
市值:26.70億
市盈率:13.96
高:22.05
開:21.58
低:21.40
收:21.54
資料載入中...
2025/01/21

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/05

SEC問詢函

Form CORRESP - Correspondence
2024/10/17

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]